Evidence map›Paper›PMID 40690085›Full record

ArticleEJNMMI research2025

Evaluation of myocardial fibrosis and wall motion abnormality with

Rui Luo, Zhenyu Zhao, Chuan Zhang, Ru-Shuai Li, Yanrong Wang, Qingle Meng, Yudan Ni, Bolin Wang, Lanhua Li, Luan Feng and 5 more

Abstract read
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Research Progress in Imaging Evaluation of Myocardial Microcirculation.International journal of general medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rui LuoDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Zhenyu ZhaoDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Chuan ZhangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Ru-Shuai LiDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Yanrong WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Qingle MengDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Yudan NiDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Bolin WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Lanhua LiDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Luan FengDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Rui YangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Lin XieDepartment of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
Xin ChenDepartment of Cardiothoracic Surgery, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan. zhang.ming-rong@qst.go.jp.
Feng WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Qinhuai District, Nanjing, 210006, China. fengwangcn@hotmail.com.ORCID http://orcid.org/0000-0003-1089-3095

Funding

General Project of Science and Technology Development Fund of Nanjing Medical University NMUB2019154Jiangsu Provincial Key Research and Development Special Fund BE2017612Jiangsu Provincial Medical Key Discipline Cultivation Unit JSDW202247Nanjing Medical and Health International Joint Research and Development Project 201911042National Natural Science Foundation of China 82003532Nuclear Medicine Laboratory Open Project 2021HYX009
6 · The paper itself

Abstract

backgroundTo explore the characteristics of cardiac fibroblast activation protein inhibitor (FAPI) PET/MR in coronary heart disease (CHD) and its association with abnormal wall motion.

resultsIn this prospective study, participants with CHD after PCI (Percutaneous Coronary Intervention) underwent gallium 68 (

conclusionsSimultaneous

Indexed as

Fibroblast activation protein (FAP)Late gadolinium enhancement (LGE)PET/MR

Identifiers

PMID40690085
PMCPMC12279661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.